Dr Datasons Labs spurts on completing obligations towards FCCB bondholders

17 Jul 2014 Evaluate

Dr Datasons Labs is currently trading at Rs. 12.80, up by 0.60 points or 4.92% from its previous closing of Rs. 12.20 on the BSE.

The scrip opened at Rs. 12.80 and has touched a high and low of Rs. 12.80 and Rs. 11.70 respectively. So far 2255733 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 88.90 on 18-Oct-2013 and a 52 week low of Rs. 10.85 on 15-Jul-2014.

Last one week high and low of the scrip stood at Rs. 13.40 and Rs. 10.85 respectively. The current market cap of the company is Rs. 68.32 crore.

The promoters holding in the company stood at 10.01 % while Institutions and Non-Institutions held 56.79 % and 33.20 % respectively.

Dr Datsons Labs has successfully completed its obligations towards FCCB bondholders for $40 million. Accordingly, there is no unpaid debt by the Company towards bondholders as on July 17, 2014.

Dr. Datsons Labs is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

Peers
Company Name CMP
Sun Pharma Inds. 1788.10
Dr. Reddys Lab 1272.10
Cipla 1494.60
Zydus Lifesciences 918.00
Lupin 2105.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×